Raghunandan H V

Dr. Raghunandan H V

Member Secretary IEC BHIO

Dr. Raghunandan H V. – M.Pharm., Ph.D Head Technical Consultation – Biopharmaceuticals and Pharmaceuticals

  • Education: Registered Pharmacist
  • B.Pharm, Gold Medalist and all 4 years Topper 1993 – Mysore University
  • M.Pharm., BITS Pilani -1995
  • Ph.D., Industrial Chemistry – Kuvempu University – 2013 Worked on formulation of gall stone treatment and Anti Depressant and Anti Obesity

Professional Affiliation

  • 25+ years Professional work experience, 17 Years in Pharmaceutical and Bio Pharmaceutical Industry in India and Abroad
  • 1995 to 1996 – Management Trainee – Quality Department – Cipla Limited
  • 1996 to 2008 – GSK Positions Held – Quality Assurance Site Head, South asia Quality Senior Manager for OTC and OHC, Production and Validation Manager at GSK Philippines,
  • 2008 to 2011 – Biocon – Head of Quality Assurance / Senior Manager
  • 2011 to 2018 – JSSAHER Mysore – Professor and Deputy Director Academic & Independent Quality Auditor for Pharmaceutical and Biopharmaceuticals
  • 2018 April onwards Founder and Chief Technical Consultant at RC2 Pharma Solutions. ( Pharmaceuticals and Biopharmaceuticals Regulatory and Quality) & June 2018 onwards Technical Consultant at BHIO/HCG
  • Technical Consultant to UL Laboratories New Jersey, USA
  • Technical Consultant to United States Pharmacopoeia, Hyderabad, India

Membership in Professional Bodies in India and abroad

  • General Secretary for South India Chapter of Society for Pharmaceutical Dissolution Science, Mumbai India
  • Member of ISPE – International Society of Pharmaceutical Engineers, Tampa Florida
  • Adjunct Professor at JSSAHER Mysore, Karnataka,
  • Adjunct Professor at Acharya BM Reddy college of Pharmacy Bangalore, Karnataka.

Research Area work done till date

  • Formulation development and characterization of Anti diabetic/ Gall Stone Treatment / Anti Obsess/ Anti depressant Drugs
  • Quality and Regulatory work in the area of Anti diabetic/ Gall Stone Treatment / Anti Obsess/ Anti depressant Drugs
  • Not of Standard drugs review and policy drafting, Orphan Drugs, Irrational Drug combination/Fixed Dose combination and Regulatory policy.BA/BE studies and Clinical Trials Phase II/III/IV of anti cancer, oral Insulin, many other anti diabetic drugs.
  • Chemistry and Manufacturing Controls preparation for dossier, IND, ANDA and NDA document review
  • 12 Scientific Publication available in the Indian and International peer reviewed journals.